Platform looks to boost TCM quality
Print Edition
AN online regulation platform for traditional Chinese medicine (TCM) has opened in Anguo City, Hebei Province.
The platform, including third party approval of all medicine and transparent information on all drug producers, is sponsored by Tasly Holding Group, a pharmaceutical company in the nearby port city of Tianjin.
“TCM production has been industrialized, but illegal production and adulteration still damage the market,” said Wang Guihua, secretary-general of China Association of Traditional Chinese Medicine.
Sold by weight and mostly processed from plants and animals parts, TCM ingredients are often altered by dubious means such as soaking them in salt water to increase their weight and mixing them with cheap but similar materials.
Most TCM products lack accepted quality control standards, making foreign pharmaceutical companies and customers wary of the products’ quality. Wang says this is to be the biggest obstacle to the full internationalization of the industry.
“It’s about time to introduce a trustworthy quality regulation system to supervise every step of the production process,” said Yan Xijun, CEO of Tasly Holding Group.
The new platform can guarantee access to information on over 60 major production bases. All the drugs on the platform have been tested by a third party organization, to ensure their safety, Yan said.
Traditional Chinese medicine is rarely a prescription medication in European and US markets, but sold as food additives or health care products. However, meeting international standards has become more feasible in recent years.
Since 2010, more traditional Chinese medicine has completed the Food and Drug Administration’s trials to prepare for the US market, including the Kanglaite, an anti-cancer drug with independent intellectual property rights.
“Our efforts are paying off. Our traceability system means our foreign customers can rest assured that our products are standardized,” said Yan.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
